In 2025, CEDBCAM-RI secured four new competitive grants. Two of them launch a new research and development line on neonatal sepsis. Three strengthen our work on the genomics of antimicrobial resistance (AMR), from hospital surveillance to the training and mobility of young researchers.
2
R&D projects on neonatal sepsis
3
Projects on AMR genomics
4
Partner countries · UK, Belgium, France, Italy
Funded · 2025Research project
NeoSep-Dx
Rapid and Multiplex Analysis for Neonatal Sepsis Diagnostic
NeoSep-Dx develops a rapid, multiplex approach to diagnose neonatal sepsis, so that newborns can receive the right treatment sooner. The project was selected in the CRP-ICGEB Research Grants Programme 2025, which received 648 applications from 54 countries.
Principal Investigator: Dr Luria Leslie Founou (CEDBCAM-RI)
Funder: International Centre for Genetic Engineering and Biotechnology (ICGEB, Trieste, Italy), ICGEB–COMSTECH Joint Scientific Cooperation Programme
Duration: 1 year
Neonatal sepsisRapid diagnosticsMultiplex analysisNewborn health
Funded · 2025Collaborative research
BEACON
Building Capacity for Facility-Based Genomic Surveillance to Curb Neonatal Sepsis and Antimicrobial Resistance in Cameroon
BEACON builds the capacity of health facilities in Cameroon to carry out genomic surveillance of the bacteria responsible for neonatal sepsis and of their antimicrobial resistance.
Principal Investigator: Prof. Nicholas Thomson, Head of the Parasites and Microbes Programme, Wellcome Sanger Institute (United Kingdom)
Co-Principal Investigator: Dr Luria Leslie Founou (CEDBCAM-RI)
Partners: Wellcome Sanger Institute and University of Cambridge (Cambridge-Africa Programme), United Kingdom
Funder: Cambridge-Africa ALBORADA Research Fund, University of Cambridge
Duration: February 2026 – April 2027
Genomic surveillanceNeonatal sepsisAntimicrobial resistanceCapacity building
Funded · 2025Research project
HOSPICARE II
Whole Genome Sequencing of Biocide Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa in Healthcare Facilities in Cameroon
A multi-site extension of HOSPICARE I, conducted in 2024 with Prof. Martin Welch (University of Cambridge). The project deepens the genomic analysis of biocide and antimicrobial resistance in hospitals and strengthens strategies for the prevention and control of healthcare-associated infections.
Principal Investigator: Prof. Raspail Carrel Founou Zangue (CEDBCAM-RI)
Partner: University of Liège, Belgium
Funder: Académie de Recherche et d’Enseignement Supérieur (ARES), Belgium
Whole genome sequencingBiocide resistanceInfection prevention & controlHealthcare-associated infections
Funded · 2025Scientific mobility
BANTOU
Scientific mobility and capacity building in microbial genomics
The project builds capacity through the scientific mobility of students and young researchers. Exchanges are linked to our research in microbial genomics, antimicrobial resistance and the One Health approach.
Principal Investigator: Prof. Raspail Carrel Founou Zangue (CEDBCAM-RI)
Funder: Partenariat Hubert Curien (PHC) BANTOU, managed by Campus France, Ministry of Scientific Research and Innovation (MINRESI, Cameroon) and Ministry for Europe and Foreign Affairs (France)
Microbial genomicsAntimicrobial resistanceOne HealthTraining of young researchers
Our 2025 partners and funders
Wellcome Sanger InstituteUniversity of CambridgeICGEBCOMSTECHARESUniversity of LiègeMINRESICampus France
← Back to all projects
